// startup autopsy
Pantec Biosolutions
Drug delivery innovation lost in the valley of death.
marketfitSlow Death
Years-long decline before final shutdown · Fatal mistake: Pursued capital-intensive biotech development from a small jurisdiction without securing anchor pharma partnerships or sufficient runway to reach regulatory milestones.
Key Events Timeline
FOUNDING
Pantec Biosolutions founded in Liechtenstein to develop transdermal drug delivery technologies.
FUNDING
Secured approximately $5.6M in funding to advance transdermal platform development.
PRODUCT LAUNCH
Advanced transdermal technology toward preclinical or early clinical testing phases.
PIVOT
Attempted to license technology to pharmaceutical partners to extend runway as internal capital depleted.
SHUTDOWN
Pantec Biosolutions ceased operations after failing to secure further investment or commercial partnerships.